News
Post Doctoral Scientist post available at Boehringer - Research Beyond Borders working with the UK Cystic Fibrosis Gene Therapy Consortium
7 months ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
7 months ago Flutterby Fundraisers to Sponsor Consortium Scientist
1 year ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
1 year ago Gene Therapy Funding Update
1 year ago Consortium Student Live Facebook Interview from ASGCT
1 year ago
7 months ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
7 months ago Flutterby Fundraisers to Sponsor Consortium Scientist
1 year ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
1 year ago Gene Therapy Funding Update
1 year ago Consortium Student Live Facebook Interview from ASGCT
1 year ago
Prof Jane Davies Podcast with Lancet Respiratory Medicine
Thursday, August 11th 2016
August's issues of Lancet Respiratory Medicine is a special issue on Cystic Fibrosis.
Accompanying the issue is a podcast by our very own Prof Jane Davies. There are articles on personalized medicine in CF, classification of CF mutations and some latest data from ongoing studies with Orkambi.
You can download the podcast (mp3) here.
Prof Jane Davies's Publications.
CF Unite: Where are we now and where are we going? (2013): Dr Uta Griesenbach discusses the current gene therapy trial, the work leading up to it, and what may be just around the corner. More...
